Catalyst Wire Dossier Catalyst Wire Dossier

Ketorolac 0.4% ophthalmic solution

ketorolac tromethamine · Allergan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ketorolac 0.4% ophthalmic solution, covering 2011-09-23 to 2011-09-23. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Ketorolac 0.4% in Prostaglandin Suppression [Phase 4]

See pricing